Resources search

The economic burden of dementia in China, 1990–2030: implications for health policy

January 2017

Expand view

Objective To quantify and predict the economic burden of dementia in China for the periods 1990–2010 and 2020–2030, respectively, and discuss the potential implications for national public health policy. Methods Using a societal, prevalence-based, gross cost-of-illness approach and data from multiple sources, we estimated or predicted total annual economic costs of dementia in China. We included direct medical costs in outpatient and inpatient settings, direct non-medical costs – e.g. the costs of transportation – and indirect costs due to loss of productivity. We excluded comorbidity-related costs.

Findings The estimated total annual costs of dementia in China increased from 0.9 billion United States dollars (US$) in 1990 to US$47.2 billion in 2010 and were predicted to reach US$ 69.0 billion in 2020 and US$ 114.2 billion in 2030. The costs of informal care accounted for 94.4%, 92.9% and 81.3% of the total estimated costs in 1990, 2000 and 2010, respectively. In China, population ageing and the increasing prevalence of dementia were the main drivers for the increasing predicted costs of dementia between 2010 and 2020, and population ageing was the major factor contributing to the growth of dementia costs between 2020 and 2030.

Conclusion In China, demographic and epidemiological transitions have driven the growth observed in the economic costs of dementia since the 1990s. If the future costs of dementia are to be reduced, China needs a nationwide dementia action plan to develop an integrated health and social care system and to promote primary and secondary prevention.

Safeguarding the health sector in times of macroeconomic instability : policy lessons for low- and middle-income countries

NARAYANA, Delampady

Expand view

This publication presents the results of an international initiative to document the effects of how health systems in the developing world have responded to macroeconomic austerity and adjustment measures. Are these systems flexible and resilient to changes or are they rigid? In which circumstances and under which conditions do health systems respond favourably or unfavourably? What are the success stories? Country studies from Burkina Faso, Zimbabwe, India, Thailand, Mexico, and Colombia discuss lessons learned and identify policy measures for safeguarding the health sector

Health systems strengthening and HIV/AIDS : an annotated bibliography and resources

March 2004

Expand view

This annotated bibliography has been prepared in an effort to provide policy makers, technical personnel and other stakeholders with comprehensive information on the costs of interventions and impact of HIV on health systems. The documents included in the bibliograpy focus on those aspects of the pandemic most related to economic impact, financing and resource allocation, costing, health system strengthening, scaling up antiretroviral therapy, surveillance systems, and programme monitoring and evaluation. The bibliography describes 101 publications describing work done from 1995 onwards as well as a directory of web resources. The bibliography is not a comprehensive reveiw, but is rather intended to highlight current information in the field of HIV and health systems strengthening


Source e-bulletin on Disability and Inclusion

Subscribe to updates